Dongwha Pharm.Co.,Ltd

KOSE:A000020 Stok Raporu

Piyasa değeri: ₩204.6b

Dongwha Pharm.Co.Ltd Temettü

Temettü kriter kontrolleri 2/6

Dongwha Pharm.Co.Ltd is a dividend paying company with a current yield of 2.44% that is well covered by earnings.

Anahtar bilgiler

2.4%

Temettü verimi

n/a

Geri Alım Getirisi

Toplam Hissedar Getirisin/a
Gelecekteki Temettü Verimin/a
Temettü Büyümesi14.8%
Bir sonraki temettü ödeme tarihin/a
Eski temettü tarihin/a
Hisse başına temettü₩180.000
Ödeme oranı36%

Son temettü güncellemeleri

Dongwha Pharm.Co.,Ltd (KRX:000020) Pays A ₩120 Dividend In Just Four Days

Dec 24
Dongwha Pharm.Co.,Ltd (KRX:000020) Pays A ₩120 Dividend In Just Four Days

Recent updates

Dongwha Pharm.Co.Ltd's (KRX:000020) Promising Earnings May Rest On Soft Foundations

Mar 26
Dongwha Pharm.Co.Ltd's (KRX:000020) Promising Earnings May Rest On Soft Foundations

Is Dongwha Pharm.Co.,Ltd (KRX:000020) A Smart Pick For Income Investors?

Apr 28
Is Dongwha Pharm.Co.,Ltd (KRX:000020) A Smart Pick For Income Investors?

These 4 Measures Indicate That Dongwha Pharm.Co.Ltd (KRX:000020) Is Using Debt Safely

Mar 11
These 4 Measures Indicate That Dongwha Pharm.Co.Ltd (KRX:000020) Is Using Debt Safely

Dongwha Pharm.Co.,Ltd (KRX:000020) Has A ROE Of 8.6%

Feb 22
Dongwha Pharm.Co.,Ltd (KRX:000020) Has A ROE Of 8.6%

Is Dongwha Pharm.Co.Ltd's (KRX:000020) Share Price Gain Of 102% Well Earned?

Feb 07
Is Dongwha Pharm.Co.Ltd's (KRX:000020) Share Price Gain Of 102% Well Earned?

Should Dongwha Pharm.Co.,Ltd (KRX:000020) Be Part Of Your Dividend Portfolio?

Jan 23
Should Dongwha Pharm.Co.,Ltd (KRX:000020) Be Part Of Your Dividend Portfolio?

Is Dongwha Pharm.Co.,Ltd (KRX:000020) Popular Amongst Insiders?

Jan 08
Is Dongwha Pharm.Co.,Ltd (KRX:000020) Popular Amongst Insiders?

Dongwha Pharm.Co.,Ltd (KRX:000020) Pays A ₩120 Dividend In Just Four Days

Dec 24
Dongwha Pharm.Co.,Ltd (KRX:000020) Pays A ₩120 Dividend In Just Four Days

We're Not Counting On Dongwha Pharm.Co.Ltd (KRX:000020) To Sustain Its Statutory Profitability

Dec 19
We're Not Counting On Dongwha Pharm.Co.Ltd (KRX:000020) To Sustain Its Statutory Profitability

Is Dongwha Pharm.Co.Ltd (KRX:000020) Using Too Much Debt?

Dec 04
Is Dongwha Pharm.Co.Ltd (KRX:000020) Using Too Much Debt?

Can Dongwha Pharm.Co.,Ltd (KRX:000020) Improve Its Returns?

Nov 19
Can Dongwha Pharm.Co.,Ltd (KRX:000020) Improve Its Returns?

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: Whilst dividend payments have been stable, A000020 has been paying a dividend for less than 10 years.

Büyüyen Temettü: A000020's dividend payments have increased, but the company has only paid a dividend for 5 years.


Piyasaya Karşı Temettü Getirisi

Dongwha Pharm.Co.Ltd Piyasaya Karşı Temettü Getirisi
A000020 temettü verimi piyasa ile karşılaştırıldığında nasıldır?
SegmentTemettü Verimi
Şirket (A000020)2.4%
Pazarın Alt %25'i (KR)1.2%
Pazarın En İyi %25'i (KR)3.8%
Sektör Ortalaması (Pharmaceuticals)1.0%
Analist tahmini (A000020) (3 yıla kadar)n/a

Önemli Temettü: A000020's dividend (2.44%) is higher than the bottom 25% of dividend payers in the KR market (1.18%).

Yüksek Temettü: A000020's dividend (2.44%) is low compared to the top 25% of dividend payers in the KR market (3.75%).


Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: With its reasonably low payout ratio (35.9%), A000020's dividend payments are well covered by earnings.


Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: A000020 is paying a dividend but the company has no free cash flows.


Güçlü temettü ödeyen şirketleri keşfedin